Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CSK Biotech is a specialized biotechnology company focused on the research, development, and manufacture of high-performance cell culture media and bioprocessing solutions. Based in Suzhou, China, the company provides a comprehensive portfolio of serum-free and chemically defined media tailored for CHO, HEK293, and insect cell lines, which are essential for the production of biologics such as monoclonal antibodies, vaccines, and recombinant proteins. Beyond its product portfolio, CSK Biotech offers comprehensive CDMO services, including custom media formulation, process development, and bioprocessing optimization. The company operates state-of-the-art GMP manufacturing facilities to ensure high-quality supply for both clinical and commercial-scale bioproduction. By focusing on localized production and technical innovation, CSK Biotech aims to enhance the efficiency and cost-effectiveness of biopharmaceutical manufacturing globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CSK Biotech.